Where success begins: defining a shipment you can trust

• How do you currently define a successful sample shipment for a typical study? Options: Arrives at lab within target window, Maintains temperature within spec, Barcode and chain-of-custody complete, No regulatory findings on receipt, Other
• In a typical month, how many clinical shipments does your team move that require temperature control? Options: 0-50, 51-200, 201-1,000, 1,001-5,000, 5,000+
• Tell me about the mix of collection types you handle, for example frozen plasma, room-temperature swabs, or cryopreserved cells. Options: Frozen plasma/serum, Cold chain refrigerated (2-8°C), Frozen with dry ice, Ambient stabilized kits, Cryopreserved/ultra-low
• Which single metric would make you call a pilot a clear success and accelerate contracting? Options: % shipments within temp spec, Time-in-transit target met, Complete chain-of-custody records, Zero sample rejections at lab, Other

Where the current process trips you up

• If one critical handoff failed tomorrow, how certain are you you could reconstruct chain of custody and recover the sample's value? Options: Completely certain, Mostly certain with effort, Uncertain, Not possible
• Describe the last time a temperature excursion occurred in a study you run, what caused it, and what the downstream impact was.
• Which parts of the transfer chain cause the most friction: site packing, local courier pickup, international transit, or receiving lab logging? Options: Site packing, Local courier pickup, International transit, Receiving lab logging, Multiple of the above
• Who on your team currently becomes the escalation owner when a shipment is out of temperature, and how long does it take to get an initial response? Options: Clinical supply lead, QA/Compliance, Logistics coordinator, Lab operations, No single owner
• Which single failure mode would make you stop a deployment immediately, for example repeated barcode mismatches or systemic temperature excursions? Options: Systemic barcode mismatches, Repeated temperature excursions, Missing chain-of-custody records, Regulatory nonconformance at receiving lab, Other

Who needs to be in the room when problems surface

• Who are the decision makers and approvers that must sign off on a change to your sample logistics process? Options: Clinical supply director, QA/Regulatory lead, Lab director, Procurement, IT/Integration owner, Other
• When a sample-related regulatory question arises during a filing, who on your side typically responds to auditors and how much lead time do they need? Options: QA/Compliance within 24 hours, Lab director within 48 hours, Clinical operations within a week, Depends on case
• Which reporting cadence helps your leadership feel confident, real time alerts, daily digest, or weekly summaries? Options: Real time alerts, Daily digest, Weekly summary, Custom dashboard with filters
• If the pilot demonstrates the target metric, who can sign commercial terms and how fast could they approve a vendor? Options: Clinical supply director within 1 week, Procurement within 2-4 weeks, Requires executive review 4+ weeks, No clear authority

The sample details that actually matter

• Which site distribution best describes your upcoming program, number of sites and spread across regions? Options: Single country, <50 sites, Multi-country, 50-200 sites, Global, 200-1,000 sites, Highly distributed with remote locations
• How many different temperature profiles do you routinely manage across your studies, for example 2-8°C, frozen, ambient stabilized? Options: One profile, Two profiles, Three profiles, More than three
• Describe your kit provisioning model, who prepares kits, where they are stored, and how inventory is tracked.
• Which barcode identity checks do you currently require at collection and at receipt, for example 1D barcode scan, 2D matrix, and human read confirmation? Options: 1D barcode scan, 2D matrix scan, Barcode plus human read, RFID, No standard today
• Which of these constraints would kill a pilot for you: inability to monitor temperature in real time, lack of API for LIMS, or no named courier lanes? Options: No real-time temperature monitoring, No LIMS/CTMS API access, No dedicated courier lanes, None of these would kill it

Stories that reveal how recovery really works

• When a shipment has failed in the past, what sequence of steps did your team follow to contain the issue and what took the most time?
• Who typically owns communications to study sites about sample issues, and how do sites prefer to receive those notifications? Options: Clinical operations email, Site portal notification, Phone/SMS to site coordinator, Local CRA
• If an exception event required sample replacement, what is your acceptable replacement window before data quality is compromised? Options: 24 hours, 48 hours, 72 hours, Depends on sample type
• Tell me about one recovery that worked well and one that did not, and what separated the two outcomes.

What your current options look like and why they might stick

• Which alternatives are you actively evaluating right now, including incumbent providers, internal build, or other vendors? Options: Incumbent logistics provider, Internal operations build, New third-party vendor, Regional courier partners, Other
• What would have to be true about your current approach for you to keep it rather than change vendors, for example cost parity, fewer audits, or better coverage? Options: Cost parity, Improved audit readiness, Better geographic coverage, Faster delivery times, Existing contractual commitment
• Has anyone on your team proposed solving this without an outside vendor, and if so what level of internal effort and timeline did they estimate? Options: Yes, small internal pilot 1-3 months, Yes, significant program 6-12 months, No internal proposal, Unsure
• Which option would be a showstopper if it stayed true, for example incumbent refuses SLA changes or internal team lacks resources? Options: Incumbent refuses SLA changes, Internal team lacks resources, No single stakeholder owns decision, Regulatory constraints prevent change

Practical readiness: systems, people, and approvals

• Which core systems must integrate for success, and do those systems provide APIs or file-based exports we can use? Options: LIMS with API, LIMS with flat file, CTMS with API, ERP/procurement, No integration needed
• Who owns the API or integration work on your side and how many dedicated FTEs can they commit during pilot integration? Options: IT integration team, 1-2 FTEs, LIMS team, 1 FTE, No internal owner assigned, External integrator
• Is the sample metadata needed for chain-of-custody clean and accessible, for example patient IDs, visit numbers, collection timestamps, and site identifiers? Options: Yes, fully accessible, Partially available with cleanup, Not currently available, Unsure
• Which regulatory approvals or legal reviews could gate a pilot start, such as IRB approvals, data transfer agreements, or import permits? Options: IRB/ethics approvals, Data transfer agreement, Import/export permits, No known gates, Other
• If integrations or approvals add more than four weeks to the schedule, would that rule out a Q4 pilot for you? Options: Yes, unacceptable delay, Acceptable with mitigation, Depends on criticality

Acceptance signals and the decision that follows

• What measurable acceptance criteria must the pilot meet for you to move to enterprise rollout, for example 95% shipments within temperature spec and full LIMS field mapping? Options: % shipments within temp spec, Complete LIMS/CTMS integration, Zero sample rejections, Courier lane coverage verified, Other
• If the pilot proves those acceptance criteria, what is the earliest your organization could complete contracting and begin phased rollout? Options: Immediately within 1 week, 2-4 weeks, 1-2 months, 3+ months
• Which commercial or compliance concern would block you from moving forward even if pilot metrics are met, for example unresolved data residency or unacceptable SLA terms? Options: Data residency, SLA terms, Pricing, Insurance/liability, Other
• Who needs to sign final acceptance and what single action would accelerate them to sign within a week? Options: Clinical supply director, Procurement, QA/Regulatory, Executive sponsor
• Describe the next three practical steps from your perspective that would move this from conversation to an executed pilot.

• Solution Experience Session

• You confirm the demonstrated workflows remove the rework and lab rejections you described.
• Confirm the current state and its cost to your team
• Deliver a site-level operational runbook for the two reviewed scenarios showing handoffs, barcode checkpoints, temperature thresholds, and exception playbooks within five business days.
• You confirm the recovery procedures produce the audit evidence needed for regulatory review.
• End-to-end operational walkthrough using your workflow
• Provide shipment logs, prior incident reports, and a sample of your LIMS field mappings for the two pilot sites before the pilot kickoff.
• Confirm pilot sites and a two-week window for scheduled proof shipments so the seller can prepare monitoring and reporting.
• Failure scenario 1, temperature excursion proof
• You agree on pilot acceptance criteria and the remaining integration evidence required before decision.
• Failure scenario 2, identity or mislabeling proof
• Validate integrations, alerts, and acceptance criteria
• Forced validation checkpoint
• Agree next evidence steps and pilot criteria

• Solution Experience Session
• Solution Experience Deck
• Solution Brief: Operational Runbook and Acceptance Criteria

• meeting
• slides
• document

• Provide pre-barcoded specimen collection kits
• Deploy validated temperature-controlled packaging solutions
• Execute global temperature-controlled sample shipments
• Provision temperature loggers and deliver monitoring data
• Continuous temperature monitoring with excursion alerting
• Capture barcode identity verification at every handoff
• Digital chain-of-custody records and audit package delivery
• Central laboratory receiving, accessioning, and sample logging
• Biorepository cold storage, inventory, and controlled retrieval
• LIMS and CTMS integration and status synchronization
• Customs-ready import/export documentation and clearance filings
• Exception handling: recovery, quarantine, and rerouting services
• Regulated sample disposition and certificate of destruction

Provide pre-barcoded specimen collection kits

• How many distinct kit SKUs and part numbers will you require for the program (e.g., PKG-001 blood tube kit, PKG-002 urine kit)?
• Which barcode symbologies must the pre-barcoded labels use for downstream lab ingestion (e.g., GS1-128, Code 128, QR, UUID)? Options: GS1-128, Code 128, QR, UUID, Other
• List the label data elements that must be pre-printed on each kit (for example: subject ID, visit number, collection date/time, kit lot, kit expiry).
• Do you require pre-assembled consumables or cold packs inside the kit (for example: gel packs pre-conditioned to 2-8°C, desiccant, cryovials)? Options: Yes, No
• Who in your team will approve final kit artwork and batch lot release (provide role/title that signs the kit lot release certificate)?
• Specify expected monthly kit consumption and per-site buffer stock level (example: 200 kits/site/month with 50-kit safety stock).

Deploy validated temperature-controlled packaging solutions

• Which target temperature profile must the packaging validation cover for your samples (choose the profile used for validation testing, for example 2-8°C, -20°C, or -80°C)? Options: 2-8°C, -20°C, -80°C, Ambient, Custom
• Indicate the maximum transit duration per shipping lane the packaging must maintain the target temperature for (for example: 48 hours, 72 hours, 120 hours). Options: <24 hours, 24-48 hours, 48-72 hours, 72-120 hours, >120 hours
• Describe the validated test condition you require for packaging approval (for example: payload mass, ISTA-style profile, external ambient extremes, pre-conditioning steps).
• Which insulation or refrigerant types are acceptable for your study kits (for example: phase-change material rated to hold 2-8°C, dry ice with validated sublimation profile)? Options: Phase-change material (PCM), Gel/ice packs, Dry ice, Vacuum insulated panel, Other
• What acceptance criteria will confirm packaging validation for your temperature profile (for example: maintain 2-8°C for 72 hours with no excursions outside ±2°C and internal logger trace attached)?
• Provide the expected payload configuration to validate (example: number of vials, total sample mass, packaging dimensions and weight).

Execute global temperature-controlled sample shipments

• Which origin and destination lanes must be covered in the global network (list country pairs or regions and typical transit time expectations per lane)?
• Do the shipments require door-to-door service or door-to-airport handoff for specific lanes (select applicable delivery scope)? Options: Door-to-door, Door-to-airport, Airport-to-airport, Hybrid
• Which airwaybill (AWB) and manifest data elements must accompany each shipment for customs and receiving (for example: consignee name, IOR number, Harmonized System code, sample description)?
• Are there lanes that require pre-filed import permits or controlled substance paperwork for biological specimens (identify country and permit type required)? Options: Yes, No
• Provide the required pickup windows and site-level collection cutoffs for scheduled courier pick-ups (example: 09:00-11:00 local for clinical sites).
• Which transit-time SLAs do you require by lane (for example: next-business-day, 48-hour, 72-hour) and what is the maximum allowable deviation before escalation?

Provision temperature loggers and deliver monitoring data

• Which logger type do you require to be provisioned with shipments: real-time telematics (cellular/GPS), Bluetooth-enabled loggers, or passive data loggers that are downloaded at receipt? Options: Real-time telematics, Bluetooth-enabled, Passive data logger, Other
• How must logger data be linked to specimens: by kit barcode, AWB number, or LIMS accession ID? Options: Kit barcode, AWB number, LIMS accession ID, Other
• What data format and delivery method do you require for logger traces (for example: CSV or JSON via SFTP, portal download, or webhook payload)? Options: CSV via SFTP, JSON webhook, Portal download, Other
• Are current calibration certificates required with each logger batch (for example: ISO/IEC 17025 or supplier calibration certificate)? Options: Yes, No
• Describe the minimum logger battery life or operational window required to cover longest lane transit (for example: 7 days battery life with 1-minute sampling).
• Which metadata must the logger deliver with the trace for audit (for example: logger serial number, start/stop timestamps, timezone, time-stamped temperature samples)?

Continuous temperature monitoring with excursion alerting

• Which temperature thresholds should generate an initial excursion alert for each profile (for example: breach of 2-8°C by ±2°C for more than 10 minutes)?
• Through which channels do you want real-time alerts delivered (select all that apply: email, SMS, portal notification, webhook to your system)? Options: Email, SMS, Portal notification, Webhook
• What escalation timeline do you require after an initial alert before automatic rerouting is initiated (for example: 30 minutes to contact site, 2 hours to activate contingency)?
• Do you require automated heatmap or event summaries for each excursion for inclusion in the audit package (for example: summary PDF with trace and event annotations)? Options: Yes, No
• Indicate the maximum allowable cumulative excursion time per shipment before the sample is flagged for quarantine (example: cumulative 15 minutes outside target range).
• Who are the nominated escalation contacts and roles to be notified during a temperature event (provide role/title and 24/7 contact method)?

Capture barcode identity verification at every handoff

• At which handoff points must you capture a barcode scan (select from: site collection, courier pickup, airport handoff, customs, receiving laboratory, biorepository)? Options: Site collection, Courier pickup, Airport handoff, Customs, Receiving laboratory, Biorepository
• Which verification checks are required at each scan event (example: barcode present and readable, subject ID matches LIMS subject ID, kit lot matches manifest)?
• Do you require offline-capable handheld scanners with batch sync for remote sites with intermittent connectivity? Options: Yes, No
• What tolerance or acceptance rules should trigger a manual reconciliation at scan time (for example: barcode mismatch, missing field, or duplicate scan within 5 minutes)?
• Specify any barcode label durability requirements for your sample type (for example: cryogenic label resistant to -80°C, chemical exposure resistance).
• Identify the mandatory fields that must be captured in the scan transaction for LIMS ingestion (for example: sample barcode, scan timestamp with timezone, operator ID, GPS/location).

Digital chain-of-custody records and audit package delivery

• Which artifacts must be included in the digital audit package for each shipment (for example: signed manifest, time-stamped scan trail, temperature trace, AWB, customs clearance records)?
• What format and delivery cadence do you require for audit packages (for example: consolidated PDF per shipment delivered via SFTP within 24 hours of receipt)? Options: Consolidated PDF via SFTP, Zipped CSV/JSON via SFTP, Portal download, Webhook
• Which regulatory evidentiary standards must the audit logs meet for your filing (for example: FDA 21 CFR part 11 electronic signatures, ICH GCP traceability)? Options: FDA 21 CFR part 11, ICH GCP, ISO 9001/13485, Other
• What evidence will validate acceptance of the chain-of-custody audit package (for example: complete signed CSV manifest, time-stamped scan trail matching LIMS accession, and 21 CFR part 11 compliant audit log)?
• Do you require retention of audit packages for a specified period for regulatory inspection (specify retention period in years)? Options: 1 year, 3 years, 5 years, Custom
• Who in your organization will be the authorized recipient of audit packages and responsible for confirming package completeness (provide role/title)?

Central laboratory receiving, accessioning, and sample logging

• What are the receiving hours and cutoffs at your central lab for same-day accessioning (for example: 08:00-16:00 local, cutoff 14:00)?
• Which accession fields must be captured on receipt and mapped into LIMS (for example: accession number, sample barcode, subject ID, visit, collection datetime, condition on receipt)?
• Describe your quarantine and disposition workflow for samples that arrive with temperature excursions or missing documentation (example: isolate in quarantine freezer, notify sponsor, hold for disposition decision within 48 hours).
• Which sample rejection reasons and corresponding QC codes should be recorded at accession (for example: temperature excursion, label unreadable, leak detected)?
• Do you require automated creation of a receiving report and LIMS accession file after batch receiving (for example: daily CSV of all accessions sent to your study team)? Options: Yes, No
• Which SLA defines timely accessioning for your study (for example: samples accessioned and logged into LIMS within 4 hours of lab receipt)?

Biorepository cold storage, inventory, and controlled retrieval

• Which storage temperature zones will you require across the biorepository (for example: -80°C, -20°C, 2-8°C, ambient) and approximate sample split by zone?
• What inventory identifiers and barcodes should be used for frozen storage locations and racks (for example: freezer ID, shelf ID, box barcode)?
• How fast must controlled retrieval operate once a pull request is raised (for example: same-day retrieval within 4 hours, next-business-day)? Options: Same-day (within 4 hours), Next-business-day, 48 hours, Custom
• Do you require continuous environmental monitoring with backup power and alarm notifications for each storage zone (specify alarm recipients and thresholds)? Options: Yes, No
• What chain-of-custody artifacts should accompany each retrieved sample (for example: retrieval form, signed transfer manifest, temperature during transfer)?
• Provide any maximum storage duration rules or retention policies by sample type (for example: 5 years for serum aliquots, indefinite for DNA extracts).

LIMS and CTMS integration and status synchronization

• Which LIMS and CTMS records and fields must be synchronized with the integration endpoint (specify required fields such as sample_id, subject_id, visit, collection_time, accession_number, storage_location)?
• Which integration methods are acceptable for your systems (for example: REST API with JSON payloads, SFTP CSV drops, HL7 messaging)? Options: REST API (JSON), SFTP CSV, HL7, Other
• Provide a list of endpoint security requirements and authentication methods for the integration (for example: OAuth2 client credentials, SSH keys for SFTP, IP allowlisting).
• How should delayed or failed syncs be handled and retried (for example: retry 3 times with exponential backoff, create an exception ticket in your issue tracker)?
• What acceptance criteria will confirm integration success (for example: 99% successful status sync for accession events over a 7-day test, all mapped fields verified against sample test set)?
• Who will be the technical point of contact for integration testing and API credentials on your side (provide role/title and preferred contact method)?

• Master Services Agreement (MSA)
• Statement of Work (SOW)
• Service Level Agreement (SLA)
• Commercial Terms & Order Form
• Data Processing Agreement (DPA) with HIPAA BAA Trigger
• Escalation & Governance Matrix
• Acceptance Criteria & Change Order Procedure

• Go-live Health Check
• First Measurement Review
• Acceptance Gate — Operational Acceptance
• Quarterly Operational Review
• Annual Compliance and Continuous Improvement Review

• Implement agreed reporting or dashboard updates to improve metric visibility.
• If any criterion failed, record a concrete remediation and re-test plan with deadlines.
• Confirm legacy system decommissioning or archival is scheduled and will not remain an active operational fallback.
• Publish the acceptance decision document with recorded pass/fail results and the named signatory.
• Execute remediation actions for any failed criteria and deliver re-test evidence by the agreed deadlines.
• Complete the legacy system decommission or archive and provide confirmation of data retention and read-only access where applicable.
• KPI trends and dashboard review
• Confirm whether on-time delivery and temperature-excursion metrics remain within Solution Scope targets or require corrective action.
• Ensure high-priority operational issues are assigned and scheduled for resolution before the next quarter.
• Validate that audit-ready records are complete for the period under review.
• Close or escalate high-priority tickets with agreed deadlines and publish progress updates.
• Re-confirm success criteria and owners
• Prepare and bundle audit documentation for the next internal or external audit window.
• Year-to-date KPI summary vs Solution Scope targets
• Validate annual compliance posture by reviewing cumulative temperature-excursion rate and chain-of-custody completion rate against Solution Scope targets.
• Agree the top three continuous improvement initiatives and timelines to sustain quality and compliance.
• Confirm training and escalation updates needed to support the next year's monitoring plan.
• Approve and schedule the top continuous improvement initiatives with expected completion windows.
• Deliver a consolidated audit packet summarizing the year and corrective actions for regulatory readiness.
• Publish the agreed monitoring cadence and any revised KPI targets back into Solution Scope documentation.
• Confirm the deployment components listed in Solution Scope are operational or documented with remediation plans.
• Identify the top three operational blockers and agree remediation timelines.
• Schedule the next data-driven checkpoint and assign owners for follow-up actions.
• Document all open issues with remediation dates and publish the tracker for stakeholder review.
• Execute targeted re-tests of affected courier lanes and test shipments within the agreed window.
• Update or distribute required training materials to address observed user gaps.
• Present first measurement data vs Solution Scope targets
• Establish whether on-time sample delivery rate and temperature-excursion rate are moving toward the Solution Scope targets.
• Identify root causes for the top performance gaps and record remedial actions with resolution dates.
• Confirm the schedule and criteria for the acceptance gate meeting around day 90.
• Implement agreed remedial tasks for the highest-impact delivery and temperature issues and report status before the acceptance gate.
• Run a targeted verification batch of shipments for affected lanes and deliver results to the shared workspace.
• Correct any LIMS/CTMS field-mapping or integration errors that contributed to chain-of-custody gaps.
• Restate acceptance criteria and numeric targets
• Produce a documented acceptance decision with pass/fail recorded for each Solution Scope criterion and a named signatory where required.
• Chain-of-custody and sample identity review
• Present outcome data against each criterion
• Root cause diagnosis for gaps
• Deployment and migration validation
• Regulatory audit and findings review
• Early operational signals and usage patterns
• Continuous improvement proposals and prioritization
• Document pass or fail per criterion and capture formal acceptance decision
• Open issues and enhancement request backlog
• Review chain-of-custody completeness and sample identity incidents
• Agree corrective actions and timeline to acceptance gate
• Training, ownership, and escalation governance for next year
• Audit-readiness and regulatory compliance status
• Agree remediation plan for any failed criteria
• Open issues and blockers
• Agree next-year monitoring cadence and KPI adjustments
• Agree immediate remediation actions
• Incumbent system wind-down confirmation
• Agree actions for the next quarter